Will Monsanto Company Buckle Under Anti-GMO Pressure This Week?

With the war against GMOs heating up, will Monsanto’s upcoming earnings report be a harbinger of tougher times?

Mar 31, 2014 at 1:15PM

Monsanto (NYSE:MON) investors may have started to get a little jittery about the company's future. The seed giant is set to report its second-quarter numbers this Wednesday, and Street estimates run high. But the stock hasn't kept pace with the optimism, giving up nearly 4% gains over the past three months. The market is clearly paying closer attention to the war against genetically modified crops that appears to be heating up.

Dow Chemical's (NYSE:DOW) Enlist E3 soybeans may have moved closer to receiving the U.S. Department of Agriculture's approval, but major U.S. grain exporters refused Syngenta's (NYSE:SYT) Agrisure Duracade GM corn trait last month following China's rejection even as the FDA approved the trait last year. Meanwhile, France is mulling a revival of its ban on GMO crops, and news is pouring in that Brazil may even suspend Monsanto's glyphosate Roundup herbicide.

Crwgrant Banner

Source: Monsanto.

The pressure's building up on Monsanto, but a slowdown in the company's seed sales because of all the noise against GMOs is the last thing that investors want to see. Will Monsanto's upcoming earnings report be a harbinger of tougher times ahead?

Near term looks safe
The second quarter is traditionally Monsanto's most important quarter since it coincides with the peak selling season ahead of the U.S. spring planting. Monsanto ended its first quarter with higher year-over-year prepays (advance payments) from customers in the U.S., indicating robust demand for its seeds. DuPont (NYSE:DD) also projects higher sales from its agriculture segment for the first half of the year, backed by a strong North American season.

Analysts expect Monsanto's Q2 revenue to climb 6% year over year, and see its net profit improve a good 13%. So Monsanto's profitability is actually improving, irrespective of all the opposition to its products. The company hopes to improve gross margin from its seeds and genomics by 3% to 4% this year. If its Q2 margins trend higher, Monsanto could easily meet its target.

What you should watch for
In its upcoming report, check how Monsanto plans to boost its revenue and profits when farmers are increasingly opting for soybeans over corn. Farmers are paying more attention to soybeans after the sharp jump in the crop prices in recent months. Farm Futures even expects to see a "significant shift" in acreage from corn to soybeans in the U.S. Department of Agriculture's crop report scheduled for release this week.

Lower corn acreage isn't good news for Monsanto since corn is a major growth driver -- it made up roughly 65% of its seed sales during its financial year ended Aug. 31, 2013. Soybeans contributed nearly 16% to its sales during the period.

But given that Monsanto's Roundup Ready soybean trait already covers nearly 90% of the soybeans acres in the U.S., an increase in soybean acreage should not hurt Monsanto as much as archrival DuPont, which has to license much of its genetically modified soybean traits from Monsanto and has a much smaller footprint in the soybean market. Dow Chemical hopes to edge out the Roundup Ready weed control system once its Enlist E3 goes online, but that story could take several years to unfold.

More importantly, both corn and soybeans are near-equally profitable for Monsanto. Their contribution to the company's gross profit during the last financial year matched their respective percentage contribution to its sales. So the company may be able to balance out the weakness in one product portfolio with strength in another.

Intacta Rr

Intacta RR2 PRO soybeans. Source: Monsanto.

Plans at risk?
With competition intensifying, look for details about Monsanto's planned launches for 2014 in its upcoming earnings call. Five products are ready to go online this year, including the Intacta RR2 PRO soybeans.

Remember, the company is very excited about Intacta RR2 PRO, and is betting on it heavily to gain traction in the key Latin American market. But any negative publicity out of the ongoing glyphosate-based herbicides issue in Brazil could serve a major blow to Monsanto's dreams. So make sure you don't miss the company's upcoming earnings call that could provide some valuable insight.

The Foolish bottom line
While growing concerns about GMOs is worrisome, Monsanto investors may have a real problem in hand if the company downgrades its earlier 2014 projection of at least 10% upside on its earnings per share. I don't see that coming, though, but even a small hint of doubt in management's words could send the seemingly vulnerable shares down. But before you decide to act, make sure to check back at Fool.com for detailed analysis on Monsanto's earnings and plans for the future. 

Three stock picks to ride America's energy bonanza
You already know record oil and natural production is changing the lives of millions of Americans. But what you probably haven't heard is that the IRS is encouraging investors to support our growing energy renaissance, offering you a tax loophole to invest in some of America's greatest energy companies. Take advantage of this profitable opportunity by grabbing your brand-new special report, "The IRS Is Daring You To Make This Energy Investment!," and you'll learn about the simple strategy to take advantage of a little-known IRS rule. Don't miss out on advice that could help you cut taxes for decades to come. It's a free report, so click here now to learn more.

Neha Chamaria has no position in any stocks mentioned, and neither does The Motley Fool. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers